Martine A. Rothblatt's family trust made ten sales on October 13, 2026, under a pre-arranged trading plan adopted on November 7, 2025.

Another $145.4M from Liquidia covers ongoing Yutrepia sales to PH-ILD patients, payable in two $72.7M installments by January 31 and April 30, 2027.

Liquidia will pay out $380.7 million as part of a settlement agreement with United Therapeutics Corp. that resolves six lawsuits between the pharmaceutical companies, Liquidia announced Tuesday, saying patients will continue to have access to its Yutrepia lung disease treatment that was central to litigation.

Liquidia will pay out $380.7 million as part of a settlement agreement with United Therapeutics Corp. that resolves six lawsuits between the pharmaceutical companies, Liquidia announced Tuesday, saying patients will continue to have access to its Yutrepia lung disease treatment that was central to litigation.

The options carried a $117.76 exercise price, leaving 252,410 options after exercise. The trading plan was adopted November 7, 2025.

A subgroup analysis found ralinepag lowered clinical-worsening risk regardless of baseline noninvasive low-risk criteria; CHEST runs Oct. 18–21 in Phoenix.

United Therapeutics presentó un nuevo producto llamado Tresmi, que es "una formulación patentada de treprostinil en un inhalador de niebla suave".